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Objectives: This study aimed at evaluating the AID ESBL line probe assay for the detection of extended-spectrum
b-lactamase (ESBL) and KPC carbapenemase genes in Enterobacteriaceae.
Methods:TheAIDESBL lineprobeassaywasverified foraccuracyof its probesusingPCRproducts fromclinical ESBL
Enterobacteriaceae strains harbouring TEM, SHV and CTX-M ESBL genes and KPC genes and mutant fusion PCR
products generated from Enterobacteriaceae strains containing wild-type (wt) TEM and wt SHV. Sensitivity and
specificity was determined testing a set of 424 clinical Enterobacteriaceae strains (including 170 strains negative
for TEM, SHV, CTX-M and KPC to evaluate the possibility of false positive signals).
Results: The line probe assay was shown to detect with 100% accuracy ESBL genes for which oligonucleotide
probes are present in the assay. Testing a set of 424 clinical Enterobacteriaceae strains showed 100% sensitivity
and specificity for the detection and differentiation of TEM, SHV and CTX-M ESBL genes present in that group.
In addition, the line probe assay detected KPC genes accurately.
Conclusions: The AID ESBL line probe assay is an accurate and easy-to-use test for the detection of ESBL and KPC
genes, which can readily be implemented in the diagnostic laboratory.
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Introduction
Increasing prevalence of resistance against cephalosporins in
extended-spectrum b-lactamase (ESBL)-producing Enterobacter-
iaceae has continuously been reported over the past years.
Depending on the ESBL type, these b-lactamases have the ability
tohydrolyse variouspenicillins, first-, second-and third-generation
cephalosporins, and aztreonam (but not cephamycins or carbape-
nems). Currently, the most prevalent ESBLs include TEM, SHV and
CTX-Menzyme types.1,2While TEMandSHVb-lactamasewild-type
(wt) genes have to evolve to ESBL by mutation, all CTX-M-type
enzymes naturally show ESBL activity. To date, .170 SHV, .200
TEM and 130 CTX-M variants (clustered in five groups: CTX-M-1,
CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25) have been identified
(for an update see http://www.lahey.org/studies). CTX-M-type
b-lactamase-producing Escherichia coli have emerged in recent
years and CTX-M enzymes are now the most prevalent ESBL type
in Europe and North America.3,4 While Klebsiella pneumoniae
and E. coli strains represent the most frequently isolated ESBL-
producing species worldwide, ESBLs have been identified in
several other members of the Enterobacteriaceae family, such as
Enterobacter cloacae and Klebsiella oxytoca.5
Phenotypic susceptibility testing for ESBLsmay be complicated
by the presence of multiple b-lactamases in a single bacterial
strain, e.g. ESBLs, AmpCs and carbapenemases, and by different
levels of b-lactamase gene expression.6,7 Genotypic tests have
the potential to accurately identify different b-lactamase genes
and mutations that result in ESBLs.8
Based on epidemiological analyses, an ESBL line probe assay has
been designed (AID Autoimmun Diagnostika GmbH, Germany) to
detect themost prevalent ESBL genes present in Enterobacteriaceae
in Europe and North America and the KPC carbapenemase gene
(Figure 1 and Table S1, available as Supplementary data at JAC
Online). The aimof this studywas to evaluate the specificity and sen-
sitivity of the AID ESBL line probe assay (AIDAutoimmunDiagnostika
GmbH, Germany) in clinical Enterobacteriaceae strains.
Methods
Strains, culture conditions and fusion PCR amplicons
In this study, we used a carefully characterized collection of non-duplicate,
non-outbreak, clinical Enterobacteriaceae strains (n¼424; Table S2, avail-
able as Supplementary data at JAC Online). These strains were isolated
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fromclinical specimens frompatients fromtertiaryandsecondarycarehos-
pitals in the Zurichmetropolitan area (Switzerland, Europe) over a period of
7 months from October 2009 until April 2010. Previously, we have charac-
terized this set of clinical strains phenotypically and genotypically for the
presence of ESBL genes.8 Fusion PCR amplicons were generated for ESBL
TEM and ESBL SHV mutations that were not available to us from clinical
isolates. For details, see the Supplementary methods and Table S3 (both
available as Supplementary data at JAC Online).
AID ESBL line probe assay
The AID ESBL line probe assay can detect ESBLTEM (E104K, R164S, R164H
and G238S), ESBL SHV [D179A, D179G, D179N and mutant amino acids
(aas) 238/240] and CTX-M genes (all known classes) (Figure 1 and
Table S1, available as Supplementary data at JAC Online). In addition, a
probe for one of the most prevalent carbapenemases in Europe and
North America, i.e. KPC, is included.
AID ESBL line probe assay testing was performed following the manu-
facturer’s instructions (AID Autoimmun Diagnostika GmbH, Germany).
Briefly, the procedure for bacterial cultures consists of DNA extraction (la-
boratories are free to choose their own method), PCR amplification with
primers for the ESBL and KPC target genes (2.5 h), reverse hybridization
of the PCR amplicons with the probes present on the nitrocellulose strip
(1 h) and, finally, signal development (1 h). A DNA isolation kit and
thermostable DNA polymerase are not provided in the AID ESBL kit. The
kit contains primers for PCR amplification and reagents for line probe
reverse hybridization and signal detection. TheDNAused for PCR amplifica-
tion with the biotinylated primers of the AID ESBL kit was either extracted
frombacterial coloniesgrownonsheepbloodagarmediumusingtheInsta-
Gene Matrix (Bio-Rad, Reinach, Switzerland; DNA extraction time 3 h), or
alternatively 200 ng of mutant fusion PCR amplicons was used. The PCR
was performed according the protocol provided with the line probe assay.
Five units of FastStart Taq Polymerase (Roche Diagnostics, Rotkreuz, Switz-
erland) together with its corresponding buffer were used per PCR.
Results
Verification analysis of the AID ESBL line probe assay
TheESBL lineprobeassay(Figure1)wasevaluatedusingPCRampli-
cons of (i) selected, phenotypically and genotypically well-
characterized clinical ESBL Enterobacteriaceae strains and (ii)
mutant fusion PCR amplicons for those TEM and SHV mutations
for which corresponding clinical strains were not available to us,
in order to verify the accuracy of all the probes present in the
assay (Table 1). The clinical strains consisted of E. coli wt TEM,
Proteus mirabilis ESBL TEM 104K/238S, K. pneumoniae wt SHV, K.
pneumoniae ESBL SHV 238S/240wt, E. coli ESBL SHV 238S/240K,
E. coli wt TEM and CTX-M group 1, E. coli wt TEM, and CTX-M
group8,Klebsiella sp.wtSHVandCTX-Mgroup9andK.pneumoniae
wt TEM, wt SHV and KPC (Table 1). Fusion PCR amplicons from wt
TEM and wt SHV genes contained introduced ESBL mutations cor-
responding to TEM 164S and TEM 164H and SHV 179A, 179G and
179N, respectively. The line probe assay detected PCR amplicons
representing ESBL and KPC genes with 100% accuracy, with no
false positive or false negative results (Table 1). The SHV 238S
PCR amplicon hybridized with two probes, i.e. wt SHV 238/240
and ESBL SHV 238/240. Other cross-reactions were not observed.
Sensitivity and specificity of the AID ESBL assay
in clinical strains
The sensitivity and specificity of the AID ESBL line probe assaywas
studied in clinical strains, using a collection of well-characterized
(molecular and phenotypic) clinical Enterobacteriaceae strains
(n¼424; 227 E. coli, 55 K. pneumoniae, 19 K. oxytoca, 61
E. cloacae and 62 strains of other species; Table S2, available as
Supplementary data at JAC Online). The nine clinical strains used
in the verification analysis (Table 1) were part of this group. The
collection contained: (i) 148 TEM-positive strains with 145 wt
TEM, 2 ESBL TEM 104K/238S and 1 strain containing two TEM
genes (ESBL TEM 104K/238S and wt TEM); (ii) 86 SHV-positive
strains with 60 wt SHV, 6 ESBL SHV 238S and 20 ESBL SHV 238S/
240K; (iii) 134 CTX-M-positive strains with 91 CTX-M group 1, 42
CTX-M group 9 and 1 CTX-M group 8; and (iv) 3 K. pneumoniae
strains with a KPC gene.
Results show an excellent performance of the ESBL line probe
assay, with a specificity and sensitivity of 100% for ESBL TEM,
ESBL SHV and CTX-M detection in this group of strains (Table 2).
Asanegative control group, to check for thepossibilityof falseposi-
tive signals in the line probe assay, we selected 170 clinical strains
characterized phenotypically as non-ESBL and confirmed genetic-
ally as TEM, SHVand CTX-M negative. None of these strains, includ-
ing three K. oxytoca strains with a K1 b-lactamase gene, which is
related to CTX-M and overproduction of which can result in false
positive ESBL phenotypic testing,9 produced false positive signals.
In the absence of false positive or false negative ESBL results, the
positive predictive value and the negative predictive value of the
assay both add up to 100%.
The one E. coli strain with a wt TEM and an ESBL TEM gene
showed hybridization with both the wt and the corresponding
Probe
Conjugate control
Amplification control
Bacterial control
TEM aa 104E (wt)
TEM aa 104K (ESBL)
TEM aa 164R (wt)
TEM aa 164S (ESBL)
TEM aa 164H (ESBL)
TEM aa 238G (wt)
TEM aa 238S (ESBL)
SHV aa 179D (wt)
SHV aa 179A (ESBL)
SHV aa 179G (ESBL)
SHV aa 179N (ESBL)
SHV aa 238/240 (wt)
SHV aa 238/240 (ESBL)
CTX-M
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Figure 1. Schematic representation of the ESBL line probe assay (AID,
Strassberg, Germany) for the detection of ESBL (TEM, SHV and CTX-M) and
KPC genes in Enterobacteriaceae. TEM and SHV variants detected by the
TEM and SHV mutant probes are listed in Table S1, available as
Supplementary data at JAC Online.
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Table 1. Verification analysis of the AID ESBL line probe assay using clinical strains and fusion PCR amplicons
TEM SHV
AID
Seq.a
AID
Seq.a
CTX-M KPC
Species/fusion PCR
amplicon
wt
104E
ESBL
104K
wt
164R
ESBL
164S
ESBL
164H
wt
238G
ESBL
238S
wt
179D
ESBL
179A
ESBL
179G
ESBL
179N
wt 238/
240
ESBL
238/240 AID Seq.a AID Seq.a
E. coli + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 2 2 2 2
P. mirabilis 2 + + 2 2 2 + TEM 104K,
238S
2 2 2 2 2 2 2 2 2 2 2
TEM 164S PCR + 2 2 + 2 + 2 TEM 164S 2 2 2 2 2 2 2 2 2 2 2
TEM 164H PCR + 2 2 2 + + 2 TEM 164H 2 2 2 2 2 2 2 2 2 2 2
K. pneumoniae 2 2 2 2 2 2 2 2 + 2 2 2 + 2 wt SHV 2 2 2 2
SHV 179A PCR 2 2 2 2 2 2 2 2 2 + 2 2 + 2 SHV 179A 2 2 2 2
SHV 179G PCR 2 2 2 2 2 2 2 2 2 2 + 2 + 2 SHV 179G 2 2 2 2
SHV 179N PCR 2 2 2 2 2 2 2 2 2 2 2 + + 2 SHV 179N 2 2 2 2
K. pneumoniae 2 2 2 2 2 2 2 2 + 2 2 2 + + SHV 238S/
240wt
2 2 2 2
E. coli 2 2 2 2 2 2 2 2 + 2 2 2 2 + SHV 238S/
240K
2 2 2 2
E. coli + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 + CTX-M
group 1
2 2
E. coli + v + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 + CTX-M
group 8
2 2
Klebsiella sp. 2 2 v 2 2 2 2 2 + 2 2 2 + 2 wt SHV + CTX-M
group 9
2 2
K. pneumoniae + 2 + 2 2 + 2 wt TEM + 2 2 2 + 2 wt SHV 2 2 + KPC
aSeq., characterization by DNA sequencing.
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Table 2. Testing of 424 clinical Enterobacteriaceae strains using the ESBL line probe assay
TEM SHV
Strains AID
Seq.a
AID
Seq.a
CTX-M KPC
group n
wt
104E
ESBL
104K
wt
164R
ESBL
164S
ESBL
164H
wt
238G
ESBL
238S
wt
179D
ESBL
179A
ESBL
179G
ESBL
179N
wt 238/
240
ESBL 238/
240 AID Seq.a AID Seq.a
1 12 + 2 + 2 2 + 2 wt TEM + 2 2 2 + 2 wt SHV + CTX-M
group 1
2 2
2 1 + 2 + 2 2 + 2 wt TEM + 2 2 2 + 2 wt SHV 2 2 + KPC
3 9 + 2 + 2 2 + 2 wt TEM + 2 2 2 + 2 wt SHV 2 2 2 2
4 1 + 2 + 2 2 + 2 wt TEM + 2 2 2 + + SHV 238S/
240wt
+ CTX-M
group 1
2 2
5 2 + 2 + 2 2 + 2 wt TEM + 2 2 2 + + SHV 238S/
240wt
2 2 2 2
6 2 + 2 + 2 2 + 2 wt TEM + 2 2 2 + + SHV 238S/
240wt
2 2 + KPC
7 2 + 2 + 2 2 + 2 wt TEM + 2 2 2 2 + SHV 238S/
240K
2 2 2 2
8 46 + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 + CTX-M
group 1
2 2
9 1 + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 + CTX-M
group 8
2 2
10 11 + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 + CTX-M
group 9
2 2
11 58 + 2 + 2 2 + 2 wt TEM 2 2 2 2 2 2 2 2 2 2 2
12 1 + + + 2 2 + + wt TEM and TEM
104K, 238S
2 2 2 2 2 2 2 2 2 2 2
13 2 2 + + 2 2 2 + TEM 104K, 238S 2 2 2 2 2 2 2 2 2 2 2
14 2 2 2 2 2 2 2 2 2 + 2 2 2 + 2 wt SHV + CTX-M
group 1
2 2
15 1 2 2 2 2 2 2 2 2 + 2 2 2 + 2 wt SHV + CTX-M
group 9
2 2
16 35 2 2 2 2 2 2 2 2 + 2 2 2 + 2 wt SHV 2 2 2 2
17 1 2 2 2 2 2 2 2 2 + 2 2 2 + + SHV 238S/
240wt
2 2 2 2
18 11 2 2 2 2 2 2 2 2 + 2 2 2 2 + SHV 238S/
240K
+ CTX-M
group 9
2 2
19 7 2 2 2 2 2 2 2 2 + 2 2 2 2 + SHV 238S/
240K
2 2 2 2
20 30 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 + CTX-M
group 1
2 2
21 19 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 + CTX-M
group 9
2 2
22 170 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
The Enterobacteriaceae strains (for species see Table S2, available as Supplementary data at JAC Online) were isolated from urine, wound, respiratory tract, groin, blood culture, vagina,
miscellaneous and other unspecified body sites. TEM and SHV genes were sequenced for mutation identification. Classification of CTX-M genes was based on multiplex PCRs, which
differentiate between the different CTX-Ms.14,15
aSeq., characterization by DNA sequencing.
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mutant probe in the line probe assay. This result was confirmed by
thesequencingofTEMPCRamplicons,whichdemonstrateddouble
peaks at the location of the corresponding nucleotide positions.
The six strains with an ESBL SHV 238S mutation (four
K. pneumoniae and two E. coli strains, see Table S2, available as
Supplementary data at JACOnline) showed an equally strong posi-
tive signal for thewt SHV238/240probe inaddition to theESBLSHV
238/240 probe. However, for none of these strains was a double
peak observed in the sequence electropherogram of the SHV PCR
amplicon at the corresponding nucleic acid positions resulting in
aa 238. Only the mutant nucleotide associated with ESBL SHV
238S was found, which indicates that only the ESBL SHV variant
is present in these strains.
Discussion
The rapid detection and accurate identification of ESBLs is crucial
for proper antibiotic therapy, to monitor resistance epidemiology
and to promptly initiate hospital hygiene procedures.6,10,11
Although ESBL strains can be detected by phenotypic screening,
the integration of genotypic methods facilitates cost-efficient
and accurate ESBL detection.8
Genotypicscreening forESBLdetection is complicatedbytheex-
istence of different ESBL enzyme classes, of which TEM, SHV and
CTX-M types are the most frequently occurring.2,5,12 Mutations
resulting in ESBLs are most frequently observed in TEM aas 104,
164 and 238 and SHVaas 179, 238 and 240.1 In general,mutation
detection in TEM and SHV genes is usually done by sequence ana-
lysis13 andCTX-Mgenes canbedetected bymultiplex PCR.14,15Few
commercial systems are available for the molecular detection of
ESBL genes. Microarrays developed by Check-Points (Wageningen,
The Netherlands) are able to detect simultaneously TEM, SHVand
CTX-Mgeneswith a high accuracy.16–18Although the assay is rela-
tively easy to perform and many probes can be included on one
array, it requires a dedicated microarray reader and software for
detection and interpretation of the results. In addition, the costs
per test are relatively high.18
In this study, we evaluated the performance of a new commer-
cially available ESBL line probeassaydevelopedbyAIDDiagnostika
(Germany), which contains probes for the most common ESBL
genes, i.e. ESBL TEM, ESBL SHV and CTX-M classes (Figure 1 and
Table S1, available as Supplementary data at JAC Online). In add-
ition, it contains a probe for the detection of KPC, which is one of
the most prevalent carbapenemases in Europe.
Theadvantages of line probeassays are that: (i) theyare easy to
perform; (ii) theyarealreadycommonlyused in themoleculardiag-
nostic laboratory19,20; and (iii) apart from a ‘simple’ PCR machine
for theperformanceof endpoint PCRs, theydonot requireaddition-
aldedicatedequipment.Adisadvantageof lineprobeassays is that
the amount of probes is restricted to15–20 probes, whereas an
array can containmore probes. Costs per test of the AID ESBLarray
in Switzerland are less than half the price of a comparable Check-
Points array.
Our results show that the line probe assay accurately detected
all mutations for which probes were present (Table 1). No false
negative or false positive result was observed for any of the ESBL
probes. However, we consistently observed that the ESBL SHV
238S showed hybridization with both the wt and the ESBL SHV
238S probes, indicating cross-reactivity of the wt SHV 238 probe
with the ESBL SHV 238S mutant. In contrast, the ESBL SHV 238S/
240K showed a hybridization signal only with the ESBL SHV 238/
240 probe, but not with the wt SHV 238 probe. Cross-reactivity of
the wt SHV 238 probe with the 238S mutant, but not with the
238S/240K mutant, is most likely due to the close clustering of
codons 238 and 240, which hampers the design of a specific
probe. However, the cross-reactivity of the wt SHV 238 probe for
the ESBL SHV238Smutant did not poseaproblem in test interpret-
ation resulting in a false negative result, as the presence of a
hybridization signal for the ESBL SHV 238/240 mutant is always
interpreted as positive for an ESBL SHV 238/240.
In the second part of this study, we analysed the specificity and
sensitivityof theESBL lineprobeassayby testingacollectionof424
clinical strains.8 All mutations present in the set of 424 clinical
Enterobacteriaceae strains were correctly identified, resulting in
100% sensitivity of the line probe assay (Table 2). One clinical
strain showed the presence of both a wt TEM and an ESBL TEM
104K/238S, which was confirmed by the presence of double
peaksat thecorrespondingnucleicacidpositions in the sequencing
electropherogram. These results show that the line probe assay is
able to detect at least two different TEM genes present in a single
strain. Cross-reactions other than the SHV 238S with the wt SHV
238/240 probe were not observed. As with every line probe
assay, the AID ESBL line probe assay is limited to the detection of
ESBLs forwhichprobesare present in theassay. In caseof apheno-
typic indication for the presence of an ESBL, but the detection of
only wt TEM or wt SHV in the line probe assay, TEM and SHV
genes can be PCR amplified followed by sequencing to resolve dis-
crepancies. In such cases, sequence analysis will detect the pres-
ence of rare or new mutations that are not included in the line
probe assay, but that result in an ESBL phenotype.
In conclusion, the ESBL line probe assay (AID) is a rapid tool for
the accurate detection of the most commonly occurring ESBL
genes in Enterobacteriaceae. It can either be used as a screening
tool or for confirmation in case of inconclusive phenotypic test
results. This assaycan readily be implemented in anydiagnostic la-
boratory possessinga ‘simple’ PCRmachine for theperformanceof
endpoint PCRs and is easy to use.
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